Citations

Clear

3042 citation(s) found for "Kumar, S".

Incidence, Admission Rates, and Economic Burden of Adult Emergency Visits for Chronic Pancreatitis
Garg, Sushil Kumar , Singh, Dupinder, Sarvepalli, Shashank , Puthanveedu, Nitin Das Kunnathu , Obaitan, Itegbemie , Haffar, Samir , Goyal, Hemant , Sanaka, Madhusudhan R. , Garg, Sushil K, Bazerbachi, Fateh

Mayo Clinic

Journal of Clinical Gastroenterology | July 20, 2018 | Volume: 53 | Issue: 8 | Pages: e328-e333

10.1097/mcg.0000000000001096 | PMID 30036238 Get It

Introduction: Chronic pancreatitis (CP) is a common reason for emergency department (ED) visits, but little research has examined ED use by patients with CP. Materials and Methods: The Nationwide Emergency Department Sample (2006 to 2012) was interrogated to evaluate trends in adult ED visits for a primary diagnosis of CP (International Classification of Disease, 9th revision, Clinical Modification code: 577.1), the rates of subsequent hospital admission, and total charges. A survey logistic regression model was used to determine factors associated with hospitalization from the ED. Results: We identified 253,753 ED visits with a primary diagnosis of CP. No significant trends in annual incidence were noted. However, the ED-to-hospitalization rates decreased by 3% per year (P<0.001) and mean ED charges after adjusting for inflation increased by 11.8% per year (P<0.001). Higher Charlson comorbidity index, current smoker status, alcohol use, and biliary-related CP were associated with hospitalization. In hospitalized patients, length of stay decreased by 2.2% per year (P=0.003) and inpatient charges increased by 2.9% per year (P=0.004). Conclusions: Patient characteristics associated with higher risk of hospitalization from the ED deserve further attention.
Serum free light chain measurements to reduce 24‐h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein
Tschautscher, Marcella , Rajkumar, S. Vincent , Lacy, Martha Q. , Gertz, Morie A. , Dingli, David , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Hayman, Suzanne R. , Zeldenrust, Stephen R., Lust, John A., Russell, Stephen J. , Kapoor, Pranshant, Lin, Yi , Kourelis, Taxiarchis , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Kaddoura, Marcella , Rajkumar, S Vincent , Lacy, Martha, Gertz, Morie A , Hwa, Lisa, Zeldenrust, Stephen, Lust, John, Russell, Stephen, Leung, Nelson , Go, Ronald S , Gonsalves, Wilson , Warsame, Rahma , Russell, Stephen J , Dingli, David , Lin, Yi , Dispenzieri, Angela , Buadi, Francis K. , Leung, Nelson , Go, Ronald S. , Gonsalves, Wilson I.

Mayo Clinic

American Journal of Hematology | July 17, 2018 | Volume: 93 | Issue: 10 | Pages: 1207-1210

10.1002/ajh.25215 | PMID 30016549 Get It

AbstractDetection of myeloma progression (PD) relies on serial 24‐h urinary M protein measurements in patients without measurable serum M spike. We examined whether serial difference free light chain (dFLC) levels could be used as a surrogate for serial 24‐h urine M protein measurements in monitoring for PD in patients with baseline measurable urine M protein. We studied 122 patients who had serial measurement of urine M protein and serum FLC and had demonstrated PD. The median increase in dFLC with progression as defined by urine M spike was 110% (IQR: 55‐312) and median absolute increase was 74 mg/dL; while 89% of patients had dFLC increase ≥ 25%, 94% had absolute increase in dFLC > 10 mg/dL, and 98% met at least 1 of these 2 criteria at PD. In patients with baseline measurable serum FLC (n = 118), 89% had increase in dFLC ≥ 25%, 97% had dFLC increase of > 10 mg/dL, and 98% had 1 of the 2. We conclude that serial dFLC assessments can be used in place of serial 24‐h urine protein assessments during myeloma surveillance to monitor for PD. Once patients have an absolute increase in dFLC of >10 mg/dL from the nadir, a 24‐h urine collection can then be assessed to document PD as per the International Myeloma Working Group criteria.
A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments
Pacheco, Jennifer A. , Rasmussen, Luke V. , Kiefer, Richard C. , Speltz, Peter, Carroll, Robert J. , Stallings, Sarah , Mo, Huan , Ahuja, Monika, Jiang, Guoqian , LaRose, Eric , Peissig, Peggy , Shang, Ning , Benoit, Barbara, Gainer, Vivian S., Borthwick, Kenneth M., Jackson, Kathryn , Sharma, Ambrish Kumar, Wu, Andy , Roden, Dan M. , Pathak, Jyotishman , Denny, Joshua C. , Thompson, William K. , Denny, Joshua C , Rasmussen, Luke V , Pacheco, Jennifer A , Campion, Thomas R , Wu, Andy Yizhou, Kho, Abel , Roden, Dan M.

Mayo Clinic

Journal of the American Medical Informatics Association | July 14, 2018 | Volume: 25 | Issue: 11 | Pages: 1540-1546

10.1093/jamia/ocy101 | PMID 30124903 Get It

Abstract Electronic health record (EHR) algorithms for defining patient cohorts are commonly shared as free-text descriptions that require human intervention both to interpret and implement. We developed the Phenotype Execution and Modeling Architecture (PhEMA, http://projectphema.org) to author and execute standardized computable phenotype algorithms. With PhEMA, we converted an algorithm for benign prostatic hyperplasia, developed for the electronic Medical Records and Genomics network (eMERGE), into a standards-based computable format. Eight sites (7 within eMERGE) received the computable algorithm, and 6 successfully executed it against local data warehouses and/or i2b2 instances. Blinded random chart review of cases selected by the computable algorithm shows PPV ≥90%, and 3 out of 5 sites had &gt;90% overlap of selected cases when comparing the computable algorithm to their original eMERGE implementation. This case study demonstrates potential use of PhEMA computable representations to automate phenotyping across different EHR systems, but also highlights some ongoing challenges.
A novel etiology for craniospinal hypovolemia: a case of inferior vena cava obstruction
Kumar, Neeraj , Neidert, Newton B. , Bjarnason, Haraldur , Diehn, Felix E. , Bjarnason, Haraldur , Campeau, Norbert G. , Morris, Jonathan M.

Mayo Clinic

Journal of Neurosurgery: Spine | July 13, 2018 | Volume: 29 | Issue: 4 | Pages: 452-455

10.3171/2018.2.spine171373 | PMID 30004315 Get It

The authors report on a patient with craniospinal hypovolemia and inferior vena cava obstruction, and describe how the two conditions may be linked. This unique report further advances the emerging literature on spinal CSF venous fistulae.
Reply to “Low prevalence of diabetes with chronic complications in patients with Takotsubo syndrome”
Desai, Rupak , Singh, Sandeep , Goyal, Hemant , Dhoble, Abhijeet , Deshmukh, Abhishek , Kumar, Gautam , Sachdeva, Rajesh , Sachdeva, Rajesh , Desai, Rupak

Mayo Clinic

Clinical Cardiology | July 12, 2018 | Volume: 41 | Issue: 8 | Pages: 1036-1037

10.1002/clc.23024 | PMID 29998519 Get It

Monoclonal Antibodies for Myeloma: Make It Easy!
Kumar, Shaji

Mayo Clinic

Journal of Oncology Practice | July 11, 2018 | Volume: 14 | Issue: 7 | Pages: 423-424

10.1200/jop.18.00350 | PMID 29996067 Get It

Clobazam monotherapy for focal or generalized seizures
Giridharan, Nisha , Anand, Vidhu , Garg, Sushil Kumar , Arya, Ravindra

Mayo Clinic

Cochrane Database of Systematic Reviews | July 11, 2018 | Volume: 2018 | Issue: 7 | Pages: No page available

10.1002/14651858.cd009258.pub3 | PMID 29995989 Get It

BALLOON-OVERTUBE ENTEROSCOPY ASSISTED (BAE) VERSUS LAPAROSCOPY-ASSISTED ERCP IN BARIATRIC POST- ROUX-EN-Y GASTRIC BYPASS PATIENTS: A COMPARATIVE STUDY
García, A Martínez-Alcalá, Kumar, Ujjwal, Kröner, PT, Jovanović, Ivan , Schwingel, Giovani , Neumann, Helmut , Mönkemüller, Klaus, García, A Martínez-Alcalá, Ahmed, Ali M.

Mayo Clinic

Endoscopy | July 10, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1637099 Get It

Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU
Sakusic, Amra , Sabov, Moldovan, McCambridge, Amanda, Singh, Tarun D. , Mukesh, Kumar, Gajić, Ognjen, McCambridge, Amanda J, Rabinstein, Alejandro A. , Kashani, Kianoush , Cook, David J. , Gajic, Ognjen

Mayo Clinic

Critical Care Medicine | July 7, 2018 | Volume: 46 | Issue: 9 | Pages: e897-e903

10.1097/ccm.0000000000003278 | PMID 29985210 Get It

Objectives: To evaluate the epidemiology of hyperammonemia unrelated to liver failure in the critical care setting. Design: Retrospective case series. Setting: Critically ill patients admitted to ICUs at Mayo Clinic, Rochester, MN (medical ICU, two mixed medical-surgical ICUs, coronary care unit, or the cardiosurgical ICU) between July 1, 2004, and October 31, 2015. Patients: Adult critically ill patients with hyperammonemia not related to acute or chronic liver failure. We excluded patients with diagnosis of moderate or severe liver disease, hyperbilirubinemia, and patients who denied the use of their medical records. Interventions: None. Measurements and Main Results: Of 3,908 ICU patients with hyperammonemia, 167 (4.5%) had no evidence of acute or chronic liver failure. One-hundred one patients (60.5%) were male with median age of 65.7 years (interquartile range, 50–74.5 yr) and median serum ammonia level of 68 µg/dL (interquartile range, 58–87 µg/dL). Acute encephalopathy was present in 119 patients (71%). Predisposing conditions included malnutrition 27 (16%), gastric bypass six (3.6%), total parenteral nutrition four (2.4%); exposure to valproic acid 17 (10%); status epilepticus 11 (6.6%), high tumour burden 19 (11.3%), and renal failure 82 (49.1%). Urea cycle defects were diagnosed in seven patients (4.1%). Hospital mortality was high (30%), and median ammonia level was higher among the nonsurvivors (74 vs 67 µg/dL; p = 0.05). Deaths were more likely in hyperammonemic patients who were older (p = 0.016), had greater illness severity (higher Acute Physiology and Chronic Health Evaluation III score, p < 0.01), malignancy (p < 0.01), and solid organ transplantation (p = 0.04), whereas seizure disorder was more common in survivors (p = 0.02). After adjustment, serum ammonia level was not associated with increased mortality. Conclusions: Hyperammonemia occurs in a substantial minority of critically ill patients without liver failure. These patients have a poor prognosis, although ammonia level per se is not independently associated with mortality. Serum ammonia should be measured when risk factors are present, such as nutritional deficiencies and protein refeeding, treatment with valproic acid, high tumour burden, and known or suspected urea cycle abnormalities.
Family-Based Mindful Eating Intervention in Adolescents with Obesity: A Pilot Randomized Clinical Trial
Kumar, Seema , Croghan, Ivana T. , Biggs, Bridget K. , Croghan, Katrina, Prissel, Rose , Fuehrer, Debbie L., Donelan-Dunlap, Bonnie, Sood, Amit , Fuehrer, Debbie, Kumar, Seema , Biggs, Bridget K

Mayo Clinic

Children | July 6, 2018 | Volume: 5 | Issue: 7 | Pages: 93

10.3390/children5070093 | PMID 29986459 Get It

Mindfulness has gained attention in the treatment of obesity. However, there is a paucity of data on family-based training in mindful eating in children. The objective of this pilot randomized clinical trial was to evaluate the feasibility and acceptability of a family-based mindful eating intervention (MEI) in adolescents with obesity, and to compare the efficacy of the MEI versus standard dietary counseling (SDC) for decreasing weight and improving cardiometabolic risk markers. Twenty-two adolescents (age 14.5–17.9 years) and parent pairs were randomized to the MEI or SDC. The MEI was administered in four 90-min sessions over 10 weeks and SDC was provided at baseline, 12 weeks, and 24 weeks. Despite the requirement of more frequent visits with the MEI, adolescents and parents attended 100% of the sessions and there were no dropouts in that group. High density lipoprotein (HDL) cholesterol increased in the SDC group, but not in the MEI group. Adolescents receiving the MEI demonstrated an increase in awareness at 24 weeks (p = 0.01) and a decrease in distraction during eating at 12 weeks (p = 0.04), when compared with the SDC group. The family-based MEI showed feasibility and acceptability in adolescents with obesity. Future studies with more intense therapy and larger sample sizes are warranted to examine the role of mindful eating in treating pediatric obesity.